Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paolo Brambilla and Franco Franceschini.
Paolo Brambilla
Connection Strength
0.423
Franco Franceschini
  1. Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab. Front Pharmacol. 2019; 10:433.
    View in: PubMed
    Score: 0.102
  2. Prevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter Study. Arthritis Care Res (Hoboken). 2018 08; 70(8):1218-1227.
    View in: PubMed
    Score: 0.097
  3. Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada. Ann Rheum Dis. 2021 Jan 27.
    View in: PubMed
    Score: 0.058
  4. Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome. Ann Rheum Dis. 2020 10; 79(10):1286-1289.
    View in: PubMed
    Score: 0.056
  5. The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al. Clin Rheumatol. 2020 08; 39(8):2489-2490.
    View in: PubMed
    Score: 0.056
  6. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020 Jul; 19(7):102568.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.